FND: Weakness Differential Clinical case Organic Clues Patient Advocacy Diagnostic Overshadowing Misdiagnosis Clinical Reasoning

Periodic Paralysis: Another Neurological Disorder Mistaken for FND

Author profile image FND Nope Moderator
0 comments

A reader recently contacted FND Nope to highlight a neurological disorder that deserves considerably more attention in discussions about FND misdiagnosis: periodic paralysis. The commenter described how children, teenagers and adults can lose years of their lives being told their episodes of weakness or paralysis are functional or anxiety-related, despite having a recognised neuromuscular disorder with specific diagnostic investigations and management options. They also pointed us towards the Facebook community Periodic Paralysis – A Rare Neuromuscular Disorder (Information & Support), where affected individuals and families share their experiences.

"Some people with this condition lose a lifetime being told their symptoms are caused by anxiety.....it's devastating and the alarming situation has to change."

Credit goes to the commenter who brought this condition to our attention and invited us to investigate it. Their warning deserves examination, particularly because the medical literature independently recognises periodic paralysis as a potential source of diagnostic confusion with functional neurological symptoms. The commenter also argued that FND lacks a scientific basis. That is a broader claim than the evidence examined here can establish. What we can investigate directly is whether patients with a recognised neuromuscular disease have been incorrectly assigned a functional diagnosis, and what investigations might have prevented it.


What is periodic paralysis?


Periodic paralysis refers to a group of rare neuromuscular disorders characterised by episodes of muscle weakness or paralysis. Several inherited forms are caused by abnormalities in ion channels that regulate electrical activity in skeletal muscle. These are known as muscle channelopathies. Depending on the type, attacks may be associated with low potassium, elevated potassium or other disturbances in muscle excitability. Episodes can last minutes, hours or sometimes days, and patients may appear entirely normal between attacks.

The major recognised forms include:

  • Hypokalemic periodic paralysis: Often associated with pathogenic variants in CACNA1S or SCN4A, with attacks typically involving low blood potassium.
  • Hyperkalemic periodic paralysis: Usually associated with SCN4A variants and episodes of weakness related to changes in potassium and muscle excitability.
  • Andersen–Tawil syndrome: Often associated with KCNJ2 variants and capable of causing periodic weakness alongside potentially dangerous cardiac rhythm abnormalities.
  • Thyrotoxic periodic paralysis: An acquired condition associated with excess thyroid hormone, frequently presenting with profound weakness and low potassium.

Symptoms frequently begin during childhood or adolescence in inherited forms. Attacks may be triggered by rest after exercise, carbohydrate-rich meals, fasting, illness, temperature changes or stress, depending on the disorder. Some patients eventually develop persistent muscle weakness. These are established physiological disorders, not conditions defined by psychological distress.


How does periodic paralysis get mistaken for FND?

The diagnostic problem is straightforward. A patient experiences episodes of severe weakness or paralysis, but by the time they see a neurologist, the attack may have resolved. Their examination can be normal, routine blood tests may reveal nothing unusual, and a standard electromyography (EMG) examination may not identify the underlying channelopathy. The resulting clinical picture can appear inconsistent if the episodic nature of the disorder is not understood.

Even potassium measurements can be misleading. Blood potassium may return to normal between attacks, and some patients experience attacks without potassium values falling outside the laboratory reference range. A negative genetic test also does not necessarily exclude periodic paralysis, because not every clinically affected patient has an identifiable pathogenic variant.

In other words, a normal examination between attacks does not establish that the attacks are functional. Neither does a normal routine EMG, a negative genetic panel or an absence of family history. Each of these findings has limitations that must be understood when investigating episodic neuromuscular disease.

The problem becomes especially disturbing when children are involved. A 2023 review of skeletal muscle channelopathies in children, published in Pediatric Neurology, explicitly discusses the risk of periodic paralysis being mistaken for functional neurological disorder. The authors describe how attacks occurring in the morning and resolving later in the day can even be misinterpreted as school avoidance. A child with an episodic muscle disorder can therefore find their symptoms attributed to behaviour rather than investigated as a possible channelopathy.

This is not merely a theoretical concern. A published case report, Atypical Presentation of Periodic Paralysis, describes a patient initially considered to have conversion disorder whose subsequent investigations identified evidence supporting periodic paralysis, including a potassium measurement of 2.3 mmol/L during an attack and abnormal electrophysiological findings. The case illustrates how a functional explanation can be overtaken by evidence of a recognised physiological disorder.


There are specific investigations

Periodic paralysis is not always easy to diagnose, but clinicians have investigations available that go beyond routine neurological examinations. Depending on the clinical presentation, these can include:

  • Measuring blood potassium during an actual attack, rather than relying exclusively on measurements taken after recovery.
  • Thyroid function testing to investigate thyrotoxic periodic paralysis.
  • Electrocardiography (ECG), particularly when Andersen–Tawil syndrome is suspected.
  • Specialised electrophysiological testing, including the long exercise test, which can detect abnormalities missed by routine EMG.
  • Targeted genetic testing for channelopathy-associated genes such as CACNA1S, SCN4A and KCNJ2.
  • Broader genetic investigations where the clinical picture warrants them and initial testing is inconclusive.

These tests are not universally indicated for every patient presenting with weakness, and no single test identifies every case. However, when the clinical history suggests episodic muscle paralysis, appropriate neuromuscular investigation matters. Treatment and preventive management also differ between periodic paralysis subtypes. Potassium supplementation, for example, may be appropriate in some circumstances but dangerous in others, making an accurate diagnosis essential.


The wider diagnostic problem


Periodic paralysis is particularly relevant to a hypothesis we have discussed repeatedly at FND Nope: that many presentations grouped under the FND label overlap with symptoms produced by established neurological, neuromuscular, autonomic and metabolic disorders. Episodic paralysis is an obvious example. The same outward symptom can arise through different physiological mechanisms, and those mechanisms cannot be determined simply by observing that a patient's weakness varies over time.

There is an important distinction between documenting that periodic paralysis can be misdiagnosed as FND and establishing how frequently this occurs. Published case reports and clinical reviews support the first conclusion. They do not provide a reliable population-wide misdiagnosis rate. The commenter described numerous affected people sharing similar experiences in the periodic paralysis community, but those accounts would need individual verification before being presented as confirmed cases.

What makes this issue worth pursuing is that the diagnostic pitfalls are already described in medical literature. Clinicians know that periodic paralysis can produce intermittent weakness, normal examinations between attacks and inconclusive routine investigations. They also know that specialised electrophysiological and genetic investigations can help identify the underlying disease. Yet published discussions and case reports show that functional or conversion-disorder explanations have entered the diagnostic picture in patients with periodic paralysis.

When a patient with an unrecognised muscle channelopathy is labelled with FND, the consequences are not merely semantic. The patient may lose access to appropriate investigations, targeted management, preventive treatment and genetic counselling. In children, delayed recognition can affect schooling, family relationships and years of development. Some periodic paralysis syndromes also carry cardiac risks that should not be overlooked.

The reader who contacted us was right to insist that periodic paralysis belongs in any serious investigation of FND misdiagnosis. We thank them for raising the issue and for directing attention towards the experiences of affected families. Their contribution has highlighted another condition that warrants closer examination, particularly in young patients whose intermittent weakness has been attributed to psychological or functional causes.

The question clinicians should be asking is not simply whether a patient's paralysis looks unusual or varies between examinations. It is whether the possibility of an episodic neuromuscular disorder has been adequately investigated before a functional diagnosis is accepted.

References